Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106890

Naturally Occurring Human Antiglobulins with Specificity for γE

Ralph C. Williams Jr., Robert W. Griffiths, Jean D. Emmons, and Richard C. Field

Department of Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87106

Department of Medicine, William Beaumont Army Hospital, El Paso, Texas 79920

Department of Medicine, Lovelace Clinic, Albuquerque, New Mexico 87108

Find articles by Williams, R. in: JCI | PubMed | Google Scholar

Department of Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87106

Department of Medicine, William Beaumont Army Hospital, El Paso, Texas 79920

Department of Medicine, Lovelace Clinic, Albuquerque, New Mexico 87108

Find articles by Griffiths, R. in: JCI | PubMed | Google Scholar

Department of Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87106

Department of Medicine, William Beaumont Army Hospital, El Paso, Texas 79920

Department of Medicine, Lovelace Clinic, Albuquerque, New Mexico 87108

Find articles by Emmons, J. in: JCI | PubMed | Google Scholar

Department of Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87106

Department of Medicine, William Beaumont Army Hospital, El Paso, Texas 79920

Department of Medicine, Lovelace Clinic, Albuquerque, New Mexico 87108

Find articles by Field, R. in: JCI | PubMed | Google Scholar

Published April 1, 1972 - More info

Published in Volume 51, Issue 4 on April 1, 1972
J Clin Invest. 1972;51(4):955–963. https://doi.org/10.1172/JCI106890.
© 1972 The American Society for Clinical Investigation
Published April 1, 1972 - Version history
View PDF
Abstract

Human sera have been examined for antibodies with specific reactivity for γE using the tanned cell hemagglutination test. Cells tanned with three different γE myeloma proteins provided a reproducible test system. Inhibition of agglutination reactions by γE proteins, but not by γG, γA, γM, or γD confirmed the specificity of these reactions. 8.5% of 304 serial serum samples obtained from miscellaneous hospitalized patients showed clear-cut anti-γ-globulins with specificity for γE. In most of these instances no definite clinical history of concomitant allergic disorders could be obtained. 53% of 73 patients with well-established allergic disorders (hay fever, extrinsic asthma) showed serum anti-γ-globulins with reactivity for γE. Some patients studied before and after desensitization to Bermuda grass allergen showed an increase in titer or a conversion from negative to positive reactions for anti-γE antibodies following several month courses of progressive desensitization. Gradient and gel filtration studies indicated that anti-γE globulins were 19S γM in all instances. No clear correlation was noted between quantitative serum γE levels and titer of anti-γE antibodies.

19S serum fractions with anti-γE antibody activity did not release histamine from normal human peripheral blood leukocytes, whereas specific rabbit anti-γE antisera consistently induced leukocytic histamine release. Moreover, macroglobulin fractions with anti-γE activity did not block allergen-specific leukocyte histamine release induced by in vitro leukocyte challenge with allergens such as Bermuda grass and leukocytes from allergic donors. In some instances 19S human serum fractions with anti-γE activity appeared to potentiate histamine release when incubated concomitantly with specific allergen and leukocytes from allergic individuals.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 955
page 955
icon of scanned page 956
page 956
icon of scanned page 957
page 957
icon of scanned page 958
page 958
icon of scanned page 959
page 959
icon of scanned page 960
page 960
icon of scanned page 961
page 961
icon of scanned page 962
page 962
icon of scanned page 963
page 963
Version history
  • Version 1 (April 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts